معرفی
Professor Peter Schmid is affiliated with the University of Sussex. His research focuses on personalized approaches to breast cancer treatment, leveraging advances in cancer biology and epigenetics. He explores novel targeted therapies, resistance modulation, and evolving research paradigms required for precision medicine.
His work addresses challenges in applying new therapeutic strategies while rethinking clinical research frameworks to optimize patient outcomes. No specific educational background, grants, or lab affiliations are detailed in the provided text.
۰مقاله منتشرشده
